Read + Share
Gainor JF, Curigliano G, Kim DW, Lee DH, et al. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a
multi-cohort, open-label, phase 1/2 study. Lancet Oncol 2021 Jun 9. pii: S1470-2045(21)00247.
PMID: 34118197
|
 |
|
Gainor JF, Curigliano G, Kim DW, Lee DH, et al. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a
multi-cohort, open-label, phase 1/2 study. Lancet Oncol 2021 Jun 9. pii: S1470-2045(21)00247.
PMID: 34118197
|
|
|
|